Basic Information
Picodya Introduces Game-Changing Technology with Proven Potential to Enable Broader Access to Diagnostics Worldwide. Founded in Early 2018 by Yehuda Yavets-Chen and Kibbutz Hatzerim.Picodya’s In Vitro Diagnostics (IVD) platform is designed for large-scale deployment at the point of care, from ICOs and hospital departments to field hospitals, clinics, and home care settings. Our goal is to make diagnostic testing accessible to everyone, everywhere, by reducing the cost per test.